PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation

BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model

Psyched Wellness Announces Key Findings from the 90-Day Oral Toxicity Study...

PT293 – Stanislav & Brigitte Grof – The Evolution of Breathwork...

Psychedelic Bulletin: Mindstate Design Labs Leaves Stealth Mode; No Synthetic Psilocybin...

Cybin Inc. Reports Third Quarter Financial Results and Recent Business Highlights

PT292 – Sam Gandy – Vital Psychedelic Conversations

Psyence Group Announces DTC Eligibility Approval in the U.S.

Cybin Announces Grant of U.S. Patent Covering its Proprietary Compound CYB004...

MYND Diagnostics Inc. Announces Participation in Approved Monash University (Australia) Government...

Load more